William Blair & Company
CLBT icon

William Blair & Company’s Cellebrite CLBT Stock Holding History

William Blair & Company’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Buy
117,645
+26,058
+28% +$393K ﹤0.01% 794
2025
Q4 		$1.65M Buy
91,587
+2,162
+2% +$38.8K ﹤0.01% 798
2025
Q3 		$1.66M Buy
89,425
+3,398
+4% +$53.4K ﹤0.01% 781
2025
Q2 		$1.38M Sell
86,027
-32,855
-28% -$586K ﹤0.01% 807
2025
Q1 		$2.31M Sell
118,882
-24,594
-17% -$518K 0.01% 680
2024
Q4 		$3.16M Buy
143,476
+19,433
+16% +$374K 0.01% 609
2024
Q3 		$2.09M Buy
124,043
+84,605
+215% +$1.26M 0.01% 699
2024
Q2 		$471K Sell
39,438
-572
-1% -$6.39K ﹤0.01% 1113
2024
Q1 		$443K Sell
40,010
-413,139
-91% -$4.22M ﹤0.01% 1113
2023
Q4 		$3.92M Sell
453,149
-3,253
-0.7% -$25.3K 0.01% 518
2023
Q3 		$3.49M Sell
456,402
-16,461
-3% -$124K 0.01% 515
2023
Q2 		$3.4M Sell
472,863
-5,948
-1% -$34.7K 0.01% 533
2023
Q1 		$2.92M Sell
478,811
-8,199
-2% -$44.4K 0.01% 571
2022
Q4 		$2.12M Sell
487,010
-12,641
-3% -$56.5K 0.01% 615
2022
Q3 		$1.96M Sell
499,651
-12,650
-2% -$63.4K 0.01% 623
2022
Q2 		$2.61M Sell
512,301
-11,677
-2% -$60.7K 0.01% 569
2022
Q1 		$3.35M Buy
523,978
+507,190
+3,021% +$3.36M 0.01% 568
2021
Q4 		$135K Buy
+16,788
New +$158K ﹤0.01% 1651

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company's CLBT Position: Q1 2026 in Review

William Blair & Company increased its Cellebrite (CLBT) stake by 28% in Q1 2026, buying an estimated $393K and bringing the position to 117,645 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #794.

William Blair & Company first reported a position in CLBT in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.92M in Q4 2023. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • William Blair & Company held 117,645 shares of Cellebrite worth $1.62M as of Q1 2026.
  • William Blair & Company bought 26,058 Cellebrite shares in Q1 2026, an estimated $393K.
  • Cellebrite made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #794 holding.
  • William Blair & Company first reported a position in Cellebrite in Q4 2021 and has held it in 18 quarters since.
  • William Blair & Company's Cellebrite position peaked at $3.92M in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.